Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Apr. 19];1(3.1):s10. Available from: https://skin.dermsquared.com/skin/article/view/78